Navigation Links
Treating High Blood Pressure May Add Years to Life
Date:12/21/2011

By Steven Reinberg
HealthDay Reporter

TUESDAY, Dec. 20 (HealthDay News) -- People suffering from high blood pressure, or hypertension, who keep their blood pressure levels under control may add years to their life, a new study suggests.

In fact, those in the study who took medicine to lower their blood pressure for more than four years reduced their risk of dying from cardiovascular disease over a 20-year period, the researchers found.

"For the first time, we prove that treating high blood pressure prolongs life," said lead researcher Dr. John Kostis, a professor of medicine & pharmacology at UMDNJ-Robert Wood Johnson Medical School in New Brunswick, N.J.

"If you take your medications for a month, you live an extra day," he said. "One day benefit from a month of treatment sounds small, but if you start treatment at 40, for example, then you live a couple of extra years."

Although the antihypertensive diuretic chlorthalidone was used in the study, it really doesn't make a difference which antihypertensive one uses; the benefit in terms of life expectancy should be the same, Kostis said.

"The main thing is to take medication to get blood pressure under control," he said. "Treat your hypertension early so you can benefit from a longer, happier life."

The report was published in the Dec. 21 issue of the Journal of the American Medical Association.

To determine the effect antihypertensive drugs might have on extending life, Kostis and his colleagues used data from the Systolic Hypertension in the Elderly Program (SHEP) trial.

In that trial, conducted between 1985 and 1990, more than 4,000 hypertensive patients were randomly assigned to take chlorthalidone or an inactive placebo. The patients in the study were an average of 72 years of age.

Kostis noted that if chlorthalidone didn't work, patients were given a beta blocker.

At the end of the trial, all of the patients were advised to get their hypertension treated, the researchers noted.

When Kostis' group looked at the 22-year follow-up data in 2006, about 60 percent of the participants had died. Of these, 59.9 percent of those taking chlorthalidone had died as did 60.5 percent of those who received placebo.

The researchers found that life expectancy and survival were longer for those who received chlorthalidone during the trial compared with those given a placebo.

The gain in life expectancy, for death from any cause, linked to treating hypertension was about half a day per month of treatment, they found.

Also, people taking an antihypertensive gained about one day free from cardiovascular death per month of treatment, and had less of a chance of dying from cardiovascular disease than those who had received placebo; 28 percent versus 31 percent, respectively.

Dr. Gregg C. Fonarow, a professor of cardiovascular medicine and science at the University of California, Los Angeles, said that "hypertension is a major modifiable risk factor for heart attacks, strokes, heart failure, renal failure and premature cardiovascular death."

Treatment of adults with elevated blood pressure with antihypertensive medications has been shown in many trials to significantly reduce the risk of fatal and nonfatal cardiovascular events, heart failure and renal failure, he said.

"However, as most trials were three to five years in duration, whether there are long-lasting effects on life expectancy from treating hypertension has not been well-studied," Fonarow said.

This study provides further compelling evidence of the enduring benefits of treating hypertension, Fonarow said.

"With over half of the 76 million men and women in the United States who have hypertension not having their blood pressure well-controlled, improved detection, treatment and control of hypertension is imperative," he added.

More information

For more information on high blood pressure, visit the U.S. Centers for Disease Control and Prevention.

SOURCES: John B. Kostis, M.D., professor, medicine & pharmacology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, N.J.; Gregg C. Fonarow, M.D., The Eliot Corday Professor of Cardiovascular Medicine and Science, University of California, Los Angeles; Dec. 21, 2011, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Europes top football venues are not prepared for treating spectators who suffer heart attacks
2. Treating Gum Disease May Thwart Preterm Births
3. Thyroid Hormone Analogue for Treating High Cholesterol
4. Thyroid hormone analogue for treating high cholesterol
5. Discovery of cellular switch may provide new means of triggering cell death, treating disease
6. Vertebroplasty: Integral to treating back pain in blood marrow cancer patients
7. Researchers identify potential new target for treating hepatitis C
8. Psychologist and Author Paul G. Swingle Talks about his Approach to Treating Depression and Mood Disorders in Online Forum
9. Sinus Dynamics Reaches Milestone with Treatment of Nasal Allergy, Sinus Infection, Acute and Chronic Sinusitis Treating 25,000th Patient
10. New targeted therapy effective in treating advanced prostate cancer
11. Anti-Aging Handbook: Top 35 Articles on Treating and Preventing Signs of Aging
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Treating High Blood Pressure May Add Years to Life 
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, ... the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where ... city’s history as home to some of the world’s leading providers of cereal and ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
Breaking Medicine Technology: